We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

LINEAR CHEMICALS S.L.U

LINEAR CHEMICALS S.L.U develops, manufactures, markets, and sells in vitro diagnostic (IVD) products including vari... read more Featured Products: More products

Download Mobile App





Linear Chemicals Presents Range of IVD Instruments and Reagents at MEDICA 2022

By LabMedica International staff writers
Posted on 13 Nov 2022

Linear Chemicals (Montgat, Spain) is presenting its range of in vitro diagnostic (IVD) products, including instruments and reagents covering clinical chemistry, serology, urinalysis, hematology, immunology, at the MEDICA 2022 Trade Fair being held in Düsseldorf, Germany from 14-17th November. More...

Among the latest instruments being presented by Linear at MEDICA 2022 is the JUNO fully automated analyzer based on the most advanced Electro-chemiluminescence Immunoassay (ECLIA) technology. More than 60 parameters are available on the instrument, covering thyroid, fertility, tumor, cardiac, inflammation, bone metabolism marker, etc. The easy-to-use eCLIA analysis system delivers an outstanding performance and rapid measurement while occupying minimum space. It has a throughput of 86 tests per hour with a time to first result of nine minutes and features technologies such as liquid level detection, clot detection and anti-collision function.

At MEDICA 2022, Linear is also showcasing the STEL-5 autoloader hematology analyzer, which is a true 5-differential automated hematology analyzer with a built-in autoloading track. STEL-5 uses flow cytometry by laser to determine white blood cells (Lymphocyte, Monocyte, Neutrophil, Eosinophil, Basophil), colorimetry to determine hemoglobin, and impedance to determinate RBC and platelets. The versatile and compact STEL-5 achieves a continuous stream of accurate and reliable results while featuring a built-in operating system and easy-to-use software.

Related Links:
Linear Chemicals


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
New
Gold Member
Serum Indices Control
Acusera Serum Indices Control
New
Gold Member
Platelet Function Analyzer
PL-12
New
Microbiology Laboratory Automation Solution
BD Kiestra™ ReadA+BarcodA
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image Credit: iStock

Prehospital Blood Test Could Reduce Emergency Transfers for Chest Pain

Chest pain leads to ambulance transport to an emergency department for about 95% of patients, although only a minority have a serious cardiac condition. Troponin testing helps assess heart muscle damage,... Read more

Molecular Diagnostics

view channel
Image: Graphical Abstract (Image Credit: Cheng N, Ouellette TW, Skead K, et al. Pre-diagnosis plasma cell-free DNA reveals early signatures of prostate and breast cancer risk up to eight years prior to clinical detection. Cell Genomics (2026). DOI:10.1016/j.xgen.2026.101364)

Blood Test Stratifies Prostate and Breast Cancer Risk Years Before Diagnosis

Cancer is the second leading cause of death globally, and late diagnosis contributes substantially to mortality. Routine screening is available for only a few cancer types, while other early detection... Read more

Immunology

view channel
Image: Aptiva utilizes particle-based multi-analyte technology (PMAT) (Photo courtesy of Werfen)

Werfen Expands Automated APS Testing with FDA-Cleared and CE-Marked IgA Reagent

Antiphospholipid syndrome (APS) is an autoimmune disorder associated with thrombosis and pregnancy complications, but its symptoms can overlap with those of other conditions, complicating diagnosis.... Read more

Microbiology

view channel
Image: RealTime Labs’ Mycotoxin Extensive Panel measures 31 mold-related toxins across seven toxin classes from a single urine sample (Photo courtesy of RealTime Labs)

New Urine Test Expands Mycotoxin Analysis to 31 Markers for Broader Exposure Assessment

Clinical evaluation of mold exposure increasingly relies on urinary mycotoxin testing, but limited marker coverage and metabolite masking can make results more difficult to interpret. Broader analysis... Read more

Technology

view channel
Image: ADLM recommends that emerging AI tools follow the same professional oversight, quality, validation, and monitoring standards as traditional clinical testing within CLIA’s existing framework (Image Credit: Adobe Stock)

ADLM Calls for CLIA Updates to Support Safe AI Use in Laboratory Medicine

Clinical laboratories increasingly use artificial intelligence to verify, interpret, and report results, but safeguards under the Clinical Laboratory Improvement Amendments (CLIA) were designed in 1992.... Read more

Industry

view channel
Image: Collaboration combines cognitive assessment, blood testing, phlebotomy, and MRI to support faster diagnosis across the UK (Image Credt: Adobe Stock)

New UK Collaboration Expands Access to Integrated Alzheimer’s Diagnostic Testing

C2N Diagnostics and Cambridge Cognition have partnered with The Alzheimer’s Trust to create an integrated pathway aimed at supporting earlier and more accurate diagnosis of Alzheimer’s disease and related dementias.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.